Nexplanon 68 MG implants
Ended Awarded
- Contract number
- SPE2DB25FTA15
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $13,805
Award facts
- Contract value 100% obligated
- $13,804.60 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $13,804.60 by the Defense Logistics Agency on September 26, 2025, for the supply of Nexplanon 68 mg implants. The contract is structured as a firm fixed-price delivery order with an ultimate completion date of October 20, 2025, and no set-aside designation was utilized in the award. This delivery order is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the Defense Logistics Agency under the SPE2DB program, a $499,999,999 single-award vehicle valid through November 2026 that enables the issuance of firm fixed-price delivery orders for a comprehensive range of pharmaceutical items supporting the medical supply needs of military health facilities worldwide.
DMS Pharmaceutical Group's core business involves distributing branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables to Department of Defense healthcare systems nationwide. The company has established itself as a crucial supplier in the federal pharmaceutical supply chain since its SAM.gov registration in 2001, consistently competing effectively in federal procurement markets through its status as a woman-owned small business. This particular delivery order for Nexplanon implants represents one of numerous pharmaceutical product deliveries the company has secured, demonstrating the breadth of its portfolio spanning contraceptive devices, oncology treatments, vaccines, injections, and specialized pharmaceutical products.
Quick answers
Who was awarded contract SPE2DB25FTA15?
SPE2DB25FTA15 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on September 26, 2025.
How much is contract SPE2DB25FTA15 worth?
The government has obligated $13,805 on SPE2DB25FTA15.
Is contract SPE2DB25FTA15 an order under another contract?
Yes. SPE2DB25FTA15 is a delivery order under SPE2DB22D9367, an indefinite delivery contract.
Was contract SPE2DB25FTA15 competed?
The extent of competition for SPE2DB25FTA15 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award